Diabetes Care in Hospital Settings

1.  Umpierrez, G. E., & Pasquel, F. J. (2017). Management of inpatient hyperglycemia and diabetes in older adults. Diabetes care, 40(4), 509-517.

2. Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, Luger A, McDonnell ME, Murad MH, Nielsen C, Pegg C, Rushakoff RJ, Santesso N, Umpierrez GE. Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2101-2128. doi: 10.1210/clinem/dgac278. PMID: 35690958; PMCID: PMC9653018.

3.  American Diabetes Association Professional Practice Committee; 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2024. Diabetes Care 1 January 2024; 47 (Supplement_1): S295–S306. https://doi.org/10.2337/dc24-S016

4. Garg R, Schuman B, Bader A, et al. Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery. Ann Surg 2018;267:858–862

5. van den Boom W, Schroeder RA, Manning MW, Setji TL, Fiestan GO, Dunson DB. Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care 2018;41:782–788

6. Setji T, Hopkins TJ, Jimenez M, et al.  Rationalization, development, and implementation

7.  of a preoperative diabetes optimization program designed to improve perioperative outcomes and reduce cost. Diabetes Spectr 2017;30:217–223

8.  Okabayashi T, Shima Y, Sumiyoshi T, et al. Intensive versus intermediate glucose control in

9.  surgical intensive care unit patients. Diabetes Care 2014;37:1516–1524

10. Institute of Medicine. Preventing Medication Errors. Aspden P, Wolcott J, Bootman JL, Cronenwett LR, Eds. Washington, DC, National Academies Press, 2007

11. Sly B, Russell AW, Sullivan C. Digital interventions to improve safety and quality of inpatient diabetes management: a systematic review. Int JMed Inform 2022;157:104596

12. Nguyen, M., Jankovic, I., Kalesinskas, L., Baiocchi, M., & Chen, J. H. (2021). Machine learning for initial insulin estimation in hospitalized patients. Journal of the American Medical Informatics Association, 28(10), 2212-2219.‏

13.  Rushakoff, R. J., Sullivan, M. M., MacMaster, H. W., Shah, A. D., Rajkomar, A., Glidden, D. V., & Kohn, M. A. (2017). Association between a virtual glucose management service and glycemic control in hospitalized adult patients: an observational study. Annals of Internal Medicine, 166(9), 621-627.‏

14.  Akiboye, F., Sihre, H. K., Al Mulhem, M., Rayman, G., Nirantharakumar, K., & Adderley, N. J. (2021). Impact of diabetes specialist nurses on inpatient care: A systematic review. Diabetic Medicine, 38(9), e14573.‏

15. Wang, Y. J., Seggelke, S., Hawkins, R. M., Gibbs, J., Lindsay, M., Hazlett, I., ... & Draznin, B. (2016). Impact of glucose management team on outcomes of hospitalization in patients with type 2 diabetes admitted to the medical service. Endocrine Practice, 22(12), 1401-1405.‏

16.  Bansal, V., Mottalib, A., Pawar, T. K., Abbasakoor, N., Chuang, E., Chaudhry, A., ... & Hamdy, O. (2018). Inpatient diabetes management by specialized diabetes team versus primary service team in non-critical care units: impact on 30-day readmission rate and hospital cost. BMJ Open Diabetes Research and Care, 6(1), e000460.‏

17.  Ostling, S., Wyckoff, J., Ciarkowski, S. L., Pai, C. W., Choe, H. M., Bahl, V., & Gianchandani, R. (2017). The relationship between diabetes mellitus and 30-day readmission rates. Clinical diabetes and endocrinology, 3, 1-8.‏

18. Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., ... & Bouillon, R. (2001). Intensive insulin therapy in critically ill patients. New England journal of medicine, 345(19), 1359-1367.‏

19. Finfer S, Chittock DR, Su SY, et al.; NICESUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283–1297

20.  Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 2011;154:268–282

21. Sathya B, Davis R, Taveira T,Whitlatch H,Wu WC. Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract 2013;102:8–15

22. Umpierrez G, Cardona S, Pasquel F, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care 2015;38:1665–1672.

23.  Zhang R, Isakow W, Kollef MH, Scott MG. Performance of a modern glucose meter in ICU

and general hospital inpatients: 3 years of real-world paired meter and central laboratory results. Crit Care Med 2017;45:1509–1514

24.  Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011;34:256–261

25.  Colunga-Lozano LE, Gonzalez Torres FJ, Delgado-Figueroa N, et al. Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus. Cochrane Database Syst Rev 2018;11: CD011296

26.  Migdal AL, Fortin-Leung C, Pasquel F,Wang H, Peng L, Umpierrez GE. Inpatient glycemic control with sliding scale insulin in noncritical patients with type 2 diabetes: who can slide? J Hosp Med 2021;16:462–468

27.  Bellido V, Suarez L, Rodriguez MG, et al. Comparison of basal-bolus and premixed insulin regimens in hospitalized patients with type 2 diabetes. Diabetes Care 2015;38:2211–2216

28. Galindo RJ, Pasquel FJ, Vellanki P, et al. Degludec hospital trial: a randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes. Diabetes Obes Metab 2022; 24:42–49

29.  Pasquel FJ, Lansang MC, Khowaja A, et al. A randomized controlled trial comparing glargine U300 and glargine U100 for the inpatient management of medicine and surgery patients with type 2 diabetes: glargine U300 hospital trial. Diabetes Care 2020;43:1242–1248

30.  Perez A, Carrasco-S_anchez FJ, Gonz_alez C, et al. Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial. BMJ Open Diabetes Res Care 2020;8:e001518

31. Brown KE, Hertig JB. Determining current insulin pen use practices and errors in the inpatient setting. Jt Comm J Qual Patient Saf 2016;42:568–575, AP1–AP7

32.  Horne J, Bond R, Sarangarm P. Comparison of inpatient glycemic control with insulin vials versus insulin pens in general medicine patients. Hosp Pharm2015;50:514–521

33. Veronesi G, Poerio CS, Braus A, et al. Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis. Clin Diabetes Endocrinol 2015;1:15

34.  Najmi U, Haque WZ, Ansari U, et al. Inpatient insulin pen implementation, waste, and potential cost savings: a community hospital experience. J Diabetes Sci Technol 2021;15:741–747

35.  Bueno E, Benitez A, Rufinelli JV, et al. Basal bolus regimen with insulin analogues versus human insulin in medical patients with type 2 diabetes: a randomized controlled trial in Latin America. Endocr Pract 2015;21:807–813

36. Galindo RJ, Dhatariya K, Gomez-Peralta F, Umpierrez GE. Safety and efficacy of inpatient diabetes management with non-insulin agents an overview of international practices. Curr Diab Rep 2022;22:237–246

37. Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol 2021;9:174–188

38. Umpierrez GE, Gianchandani R, Smiley D, et al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled studyDiabetes Care 2013;36:3430–3435

39. Fushimi N, Shibuya T, Yoshida Y, Ito S, Hachiya H, Mori A. Dulaglutide-combined basal plus correction insulin therapy contributes to ideal glycemic control in non-critical hospitalized patients. J Diabetes Investig 2020;11:125–131

40. Fayfman M, Galindo RJ, Rubin DJ, et al. A randomized controlled trial on the safety and efficacy of exenatide therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes. Diabetes Care 2019;42:450–456

41. Perez-Belmonte LM, Osuna-S_anchez J, Mill_an-G_omez M, et al. Glycaemic efficacy and safety of linagliptin for the management of noncardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study. Ann Med 2019;51:252–261

42. U.S. Food and Drug Administration. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections. Accessed 21 August 2023. Available from https:// www.fda.gov/drugs/drug-safety-and-availability/ fda-revises-labels-sglt2-inhibitors-diabetes-include -warnings-about-too-much-acid-blood-and-serious

43.  Seisa MO, Saadi S, Nayfeh T, et al. A systematic review supporting the endocrine society clinical practice guideline for the management of hyperglycemia in adults hospitalized for non-critical illness or undergoing elective surgical procedures. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgac277.

44. Ruiz de Adana MS, Colomo N, Maldonado-Araque C, et al. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease. Diabetes Res Clin Pract. 2015;110(2):158-165.

45.  Delfs N, Struja T, Gafner S, et al. Outcomes of hospitalized patients with glucocorticoid-induced hyperglycemia—a retrospective analysis. J Clin Med. 2020;9(12):4079.

46.  Radhakutty A, Burt MG. Management of endocrine disease: critical review of the evidence underlying management of glucocorticoid induced hyperglycaemia. Eur J Endocrinol. 2018;179(4):R207 -R218.

47. Seisa MO, Saadi S, Nayfeh T, et al. A systematic review supporting the endocrine society clinical practice guideline for the management of hyperglycemia in adults hospitalized for non-critical illness or undergoing elective surgical procedures. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgac277

48. Ruiz de Adana MS, Colomo N, Maldonado-Araque C, et al. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease. Diabetes Res Clin Pract. 2015;110(2):158-165.

49.  Gerards MC, Tervaert EC, Hoekstra JB, Vriesendorp TM, Gerdes VE. Physician’s attitudes towards diagnosing and treating glucocorticoid induced hyperglycaemia: sliding scale regimen is still widely used despite guidelines. Diabetes Res Clin Pract. 2015;109(2):246-252.

50. Umpierrez GE, Gianchandani R, Smiley D, et al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care. 2013;36(11):3430-3435.

51. Nyström T, Holzmann MJ, Eliasson B, Kuhl J, Sartipy U. Glycemic control in type 1 diabetes and long-term risk of cardiovascular events or death after coronary artery bypass grafting. J Am Coll Cardiol. 2015;66(5):535-543

52.  Halkos ME, Lattouf OM, Puskas JD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg. 2008;86(5):1431-1437.

53.  Ramadan M, Abdelgawad A, Elshemy A, et al. Impact of elevated glycosylated hemoglobin on hospital outcome and 1 year survival of primary isolated coronary artery bypass grafting patients. Egyptian Heart J. 2018;70(2):113-118.

54. Festejo Villamiel KM, Yao C, Sioson M. Enhanced recovery after surgery (ERAS) outcomes in patients with prior diagnosis of diabetes. J ASEAN Fed Endocr Soc. 2019;34(1):73-79.

55.  Lenguerrand E, Beswick AD, Whitehouse MR, Wylde V, Blom AW. Outcomes following hip and knee replacement in diabetic versus nondiabetic patients and well versus poorly controlled diabetic patients: a prospective cohort study. Acta Orthop. 2018;89(4):399-405.

56. Knapik P, Cieśla D, Filipiak K, Knapik M, Zembala M. Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery. Eur J Cardiothorac Surg. 2011;39(4):484-489.

57. Arslan U, Memetoğlu ME, Kutlu R, et al. Preoperative HbA1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery. Russian Open Med J. 2015;4(2):e0204.

58.  Kim HJ, Shim JK, Youn YN, Song JW, Lee H, Kwak YL. Influence of preoperative hemoglobin A1c on early outcomes in patients with diabetes mellitus undergoing off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2020;159(2):568-576.

59. Abu Tailakh M, Ishay SY, Awesat J, Poupko L, Sahar G, Novack V. Hemoglobin A1c in patients with diabetes predict long-term mortality following coronary artery surgery. J Clin Med.2021;10(12):2739.

60.  Ali F, Khilji S, Tahir S. Impact of elevated glycosylated haemoglobin on outcomes following CABG in patients with diabetes mellitus. Pakistan J Med Health Sci. 2020;14(4):1167-1169.

61. Özmen R, Tunçay A, Yılmaz H, Sarı G, Taşdemir HK. The importance of HbA1c and left ventricular ejection fraction in predicting the development of postoperative mortality and complications in coronary artery bypass graft surgery. Braz J Cardiovasc Surg. Published online July 7, 2021; doi:10.21470/1678-9741-2020-0542

62. Shoghli M, Jain R, Boroumand M, et al. Association of preoperative hemoglobin A1c with in-hospital mortality following valvular heart surgery. Braz J Cardiovasc Surg. 2020;35(5):654-659.

63. Godshaw BM, Ojard CA, Adams TM, Chimento GF, Mohammed A, Waddell BS. Preoperative glycemic control predicts perioperative serum glucose levels in patients undergoing total joint arthroplasty. J Arthroplasty. 2018;33(7s):S76-S80.

64. Strahan S, Harvey RM, Campbell-Lloyd A, Beller E, Mundy J, Shah P. Diabetic control and coronary artery bypass: effect on short-term outcomes. Asian Cardiovasc Thorac Ann. 2013;21(3):281-287.

65.  O’Sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1c) in non-diabetic and diabetic vascular patients: is HbA1c an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006;32(2):188-197.

66.  Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006;141(4):375-380.

67. Lamloum SM, Mobasher LA, Karar AH, et al. Relationship between postoperative infectious complications and glycemic control for diabetic patients in an orthopedic hospital in Kuwait. Med Princ Pract. 2009;18(6):447-452.

68. Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WL. Diabetes mellitus, hemoglobin A1c, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2012;27(5):726- 729.e721.

69. Zhuang T, Shapiro LM, Fogel N, Richard MJ, Gardner MJ, Kamal RN. Perioperative laboratory markers as risk factors for surgical site infection after elective hand surgery. J Hand Surg. 2021;46(8):675-684.e610.

70. Cunningham DJ, Baumgartner RE, Federer AE, Richard MJ, Mithani SK. Elevated preoperative hemoglobin A1c associated with increased wound complications in diabetic patients undergoing primary, open carpal tunnel release. Plast Reconstr Surg. 2019;144(4):632e-638e.

71. Colibaseanu DT, Osagiede O, McCoy RG, et al. Proactive protocolbased management of hyperglycemia and diabetes in colorectal surgery patients. Endocr Pract. 2018;24(12):1073-1085.

72.  Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T. The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab. 2010;95(9):4338-4344.

73. Matsuura K, Imamaki M, Ishida A, Shimura H, Niitsuma Y, Miyazaki M. Off-pump coronary artery bypass grafting for poorly controlled diabetic patients. Ann Cardiothorac Surg. 2009;15(1):18-22.

74. Peng W, Liang Y, Lu T, et al. Multivariate analysis of incision infection after posterior lumbar surgery in diabetic patients: a single center retrospective analysis. Medicine. 2019;98(23):e15935.

75. Hwang JS, Kim SJ, Bamne AB, Na YG, Kim TK. Do glycemic markers predict occurrence of complications after total knee arthroplasty in patients with diabetes? Clin Orthop Relat Res. 2015;473(5):1726-1731.

76. Han HS, Kang SB. Relations between long-term glycemic control and postoperative wound and infectious complications after total knee arthroplasty in type 2 diabetics. Clin Orthop Surg. 2013;5(2):118-123.

77. Laesser CI, Cumming P, Reber E, Stanga Z, Muka T, Bally L. Management of glucose control in noncritically ill, hospitalized patients receiving parenteral and/or enteral nutrition: a systematic review. J Clin Med. 2019;8(7):935.

78. Vercoza Viana M, Vercoza Viana L, Tavares AL, de Azevedo MJ. Insulin regimens to treat hyperglycemia in hospitalized patients on nutritional support: systematic review and meta-analyses. Ann Nutr Metab. 2017;71(3-4):183-194.

79. Hijaze D, Szalat A. Retrospective evaluation of glycemic control with basal-bolus or neutral protamine Hagedorn insulin regimens in patients receiving continuous enteral nutrition therapy in medicine wards. Nutr Clin Pract. 2017;32(4):557-562.

80.Hsia E, Seggelke SA, Gibbs J, Rasouli N, Draznin B. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in noncritically ill diabetic patients on continuous enteral nutrition therapy. Nutr Clin Pract. 2011;26(6):714-717.

81. Korytkowski MT, Salata RJ, Koerbel GL, et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009;32(4):594-596

82. Gregory, N. S., Seley, J. J., Dargar, S. K., Galla, N., Gerber, L. M., & Lee, J. I. (2018). Strategies to prevent readmission in high-risk patients with diabetes: the importance of an interdisciplinary approach. Current diabetes reports, 18, 1-7.‏